Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Publications

Automated Movement Detection with Dirichlet Process Mixture Models and Electromyography

Cooray N. et al, (2022), 2022 25th International Conference on Information Fusion, FUSION 2022

Altered network stability in progressive supranuclear palsy.

Whiteside DJ. et al, (2021), Neurobiol Aging, 107, 109 - 117

Rare PSAP Variants and Possible Interaction with GBA in REM Sleep Behavior Disorder.

Sosero YL. et al, (2021), J Parkinsons Dis

Longitudinal Changes in Parkinson's Disease Symptoms with and Without Rapid Eye Movement Sleep Behavior Disorder: The Oxford Discovery Cohort Study.

Liu Y. et al, (2021), Mov Disord

Reduced cortico-muscular beta coupling in Parkinson’s disease predicts motor impairment

Zokaei N. et al, (2021), Brain Communications, 3

Quantifying activities of daily living impairment in Parkinson's disease using the Functional Activities Questionnaire.

Becker S. et al, (2021), Neurol Sci

Non-motor predictors of 36-month quality of life after subthalamic stimulation in Parkinson disease.

Jost ST. et al, (2021), NPJ Parkinsons Dis, 7

Exenatide once weekly over 2 years as a potential disease-modifying treatment for Parkinson's disease: protocol for a multicentre, randomised, double blind, parallel group, placebo controlled, phase 3 trial: The 'Exenatide-PD3' study.

Vijiaratnam N. et al, (2021), BMJ Open, 11

Novel Associations of BST1 and LAMP3 With REM Sleep Behavior Disorder.

Mufti K. et al, (2021), Neurology, 96, e1402 - e1412

Validation of α-synuclein in L1CAM-immunocaptured exosomes as a biomarker for the stratification of Parkinsonian syndromes

TOFARIS G., (2021), Movement Disorders

Parkinson's Disease Subtypes: Critical Appraisal and Recommendations.

Mestre TA. et al, (2021), J Parkinsons Dis

Olfactory Testing in Parkinson's Disease & REM Behavior Disorder: A Machine Learning Approach.

Lo C. et al, (2021), Neurology

Dopaminergic imaging and clinical predictors for phenoconversion of REM sleep behaviour disorder.

Arnaldi D. et al, (2021), Brain, 144, 278 - 287

Proof of concept: Screening for REM sleep behaviour disorder with a minimal set of sensors.

Cooray N. et al, (2021), Clin Neurophysiol, 132, 904 - 913

Temporal orienting in Parkinson’s disease

Zokaei N. et al, (2021), European Journal of Neuroscience

Network Analysis of the CSF Proteome Characterizes Convergent Pathways of Cellular Dysfunction in ALS.

Thompson AG. et al, (2021), Front Neurosci, 15

Orofacial pain in 1916 patients with early or moderate Parkinson disease.

O'Neill F. et al, (2021), Pain Rep, 6

Smartphone Speech Testing for Symptom Assessment in Rapid Eye Movement Sleep Behavior Disorder and Parkinson’s Disease

Arora S. et al, (2021), IEEE Access

Comprehensive Analysis of Familial Parkinsonism Genes in Rapid-Eye-Movement Sleep Behavior Disorder.

Mufti K. et al, (2020), Mov Disord

Dopamine promotes instrumental motivation, but reduces reward-related vigour

Grogan JP. et al, (2020), eLife, 9

Load More

1
2
3
4
5
6
7
...
»

Include forthcoming?